
Leonard J. Appleman, MD, PhD, discusses prior data with SYNC-T Therapy SV-102 and the ongoing LEGION-100 study in prostate cancer.

Leonard J. Appleman, MD, PhD, is the director of the Genitourinary Cancer Disease Section, the section chief of genitourinary medical oncology, and an associate professor of medicine at the University of Pittsburgh Medical Center.

Leonard J. Appleman, MD, PhD, discusses prior data with SYNC-T Therapy SV-102 and the ongoing LEGION-100 study in prostate cancer.